Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

By Maarouf Chera L   Beach Thomas G   Adler Charles H   Shill Holly A   Sabbagh Marwan N   Wu Terence   Walker Douglas G   Kokjohn Tyler A   Roher Alex E   PD Consortium Arizona  

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 669-676

Maney Publishing

Access to resources Recommend Favorite

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

By Castaño Eduardo M.   Roher Alex E.   Esh Chera L.   Kokjohn Tyler A.   Beach Thomas  

Neurological Research, Vol. 28, Iss. 2, 2006-03 ,pp. : 155-163

Maney Publishing

Access to resources Recommend Favorite

Immunocytochemical Detection of Anti-Hippocampal Antibodies in Alzheimer's Disease and Normal Cerebrospinal Fluid

By Loeffler David A.   Juneau Paul L.   Nguyen Hanh-Uyen   Najman Dina   Pomara Nunzio   LeWitt Peter A.  

Neurochemical Research, Vol. 22, Iss. 2, 1997-02 ,pp. : 209-214

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 7, 2016-07 ,pp. : 800-808

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis

By Yang Guofeng   Wang Luning   Zhu Mingwei   Xu Dan  

Neurological Research, Vol. 30, Iss. 6, 2008-07 ,pp. : 613-622

Maney Publishing

Access to resources Recommend Favorite